Healthcare & Life Sciences
Stingray Therapeutics
United Statesstingraytx.com/
Stingray Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Stingray Therapeutics
Stingray Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Stingray Therapeutics is a clinical-stage biotech company developing Vizenpistat (SR-8541A), a small-molecule ENPP1 inhibitor that reactivates innate immunity via the cGAS-STING pathway to treat multiple solid tumor cancers, currently in Phase 1 and Phase 1b/2 clinical trials.
Explore Stingray Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.